Skip to main content

Cambridge Healthtech Institute, Wellcome Trust Sanger Institute

Cambridge Healthtech Institute’s Insight Pharma group has published “Next-Generation Sequencing: Scientific and Commercial Implications of the $1,000 Genome,” a market research report on next-generation sequencing technologies and their applications. The report covers technologies on the market or under development by Applied Biosystems, GE Healthcare, Helicos BioSciences, Illumina, Reveo, Roche/454 Life Sciences, VisiGen Biotechnologies, and others. It also includes the results of a survey of researchers at life science organizations involved with gene sequencing. 

The Wellcome Trust Sanger Institute’s Cancer Genome Project has released version 32 of the COSMIC (Catalog of Somatic Mutations in Cancer) database. COSMIC release 32 includes four new tumor suppressor genes and improved integration with the Ensembl genome browser. It includes information from 521,624 experiments, 235,207 tumors, 3,304 genes, and 445 fusions. 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.